MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$183,174K
(36.22%↑ Y/Y)
Income tax benefit
(expense)
-$530K
(-723.53%↓ Y/Y)
Loss before income
taxes
-$183,704K
(36.02%↑ Y/Y)
Product
$633,796K
(66.06%↑ Y/Y)
Royalty And Milestone
Revenue
$4,700K
Loss from operations
-$166,762K
(40.56%↑ Y/Y)
Loss on debt
extinguishment
-$10,385K
Interest expense, net
-$6,557K
(0.18%↑ Y/Y)
Revenue
$638,496K
(67.29%↑ Y/Y)
Total operating
expenses
$805,258K
(20.86%↑ Y/Y)
Loss (gain) in fair
value of contingent...
-$2,473K
(-108.79%↓ Y/Y)
Selling, general and
administrative
$570,599K
(38.71%↑ Y/Y)
Research and development
$183,279K
(-2.03%↓ Y/Y)
Cost of revenue
(excluding amortization...
$47,478K
(42.56%↑ Y/Y)
Intangible asset
amortization
$6,375K
(-0.27%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)